Replimune Group, Inc. Facing Securities Fraud Class Action Lawsuit: Seek Legal Assistance

Investors who purchased Replimune Group, Inc. securities are being encouraged to get in touch with The Gross Law Firm before September 22, 2025, to explore their legal options, as a class action lawsuit alleging securities fraud is currently pending. The lawsuit, which was filed in the United States District Court for the District of New Jersey, seeks to represent investors who bought Replimune securities between April 23, 2020, and August 4, 2025.

The lawsuit alleges that Replimune made misleading statements to investors, particularly regarding the company’s business operations and prospects. Specifically, the company is accused of misrepresenting its ability to develop a novel cancer therapy, RP1, which is designed to fight solid tumors. Replimune allegedly failed to disclose significant risks associated with the development and testing of RP1, leading investors to believe that the therapy was more advanced and closer to market approval than it actually was.

As a result of these alleged misrepresentations and omissions, Replimune’s stock price was artificially inflated during the class period. However, on August 4, 2025, the company disclosed negative clinical trial results for RP1, causing its stock price to plummet by over 67%. This drop in stock price resulted in significant financial losses for investors who had purchased Replimune securities based on the company’s alleged misrepresentations.

The lawsuit seeks to recover damages on behalf of investors who suffered losses as a result of Replimune’s alleged securities fraud. Investors who purchased Replimune securities between April 23, 2020, and August 4, 2025, are encouraged to contact The Gross Law Firm before September 22, 2025, to discuss their legal rights and options.

If you are an investor who purchased Replimune securities during the class period, it is crucial to act quickly to protect your legal rights. Securities fraud cases can be complex and challenging, but an experienced securities fraud attorney can help you navigate the legal process and pursue the compensation you deserve.

The Gross Law Firm has a track record of success in securities fraud cases and is dedicated to fighting for the rights of investors who have been harmed by fraudulent practices. Contact The Gross Law Firm today to schedule a consultation and learn more about how we can help you seek justice in the Replimune securities fraud class action lawsuit.